Abstract
Unresectable primary intimal cardio-pulmonary angiosarcoma is a rare disease with a poor prognosis without any standard treatments. Here, we report three cases of unresectable primary intimal cardio-pulmonary angiosarcoma successfully treated with the angiogenesis-inhibitor pazopanib. (Case 1) A 56-year-old female was diagnosed with unresectable recurrent primary intimal pulmonary angiosarcoma after left pneumonectomy, for which pazopanib was started. She continued pazopanib for 2 years due to stable disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
